Invasive Vulvar Tumors in Young Women-A Disease of the Immunosuppressed?

Jonathan Carter, Jay Carlson, Jeffrey Fowler, Ellen Hartenbach, Leon Adcock, Linda Carson, Leo B. Twiggs

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Twenty-seven patients under the age of 40 years were treated for invasive vulvar cancer at the Women's Cancer Center, University of Minnesota. Seventeen patients had Stage I, five patients had Stage II, two patients had Stage III, and two patients had Stage IV disease. Twenty patients (80%) gave a history of smoking. Associated medical and immunosuppressive conditions present in these patients included vulval HPV (N = 3), diabetes mellitus (N = 3), pregnancy (N = 2), autoimmune connective tissue disease (N = 2), renal transplant (N = 2), previous chemotherapy for invasive malignancies at other sites (N = 1), chronic hepatitis (N = 1), schizophrenia (N = 1), and one patient on Imuran for herpes zoster and multiple sclerosis. Two of the nonsmokers were in this group of immunosuppressed patients. Three patients have died of intercurrent disease while another is currently alive with invasive disease. All others are alive without evidence of disease. The mean duration of follow-up is 45.2 months (range, 1-158 months). Invasive vulvar tumors are uncommon in young women. Smoking and a history of an immunosuppressive medical illness is common in this patient population.

Original languageEnglish (US)
Pages (from-to)307-310
Number of pages4
JournalGynecologic Oncology
Volume51
Issue number3
DOIs
StatePublished - Dec 1993
Externally publishedYes

Fingerprint

Neoplasms
Immunosuppressive Agents
Smoking
Vulvar Neoplasms
Connective Tissue Diseases
Azathioprine
Herpes Zoster
Chronic Hepatitis
Multiple Sclerosis
Schizophrenia
Diabetes Mellitus
Transplants
Kidney
Drug Therapy
Pregnancy
Population

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Cite this

Carter, J., Carlson, J., Fowler, J., Hartenbach, E., Adcock, L., Carson, L., & Twiggs, L. B. (1993). Invasive Vulvar Tumors in Young Women-A Disease of the Immunosuppressed? Gynecologic Oncology, 51(3), 307-310. https://doi.org/10.1006/gyno.1993.1295

Invasive Vulvar Tumors in Young Women-A Disease of the Immunosuppressed? / Carter, Jonathan; Carlson, Jay; Fowler, Jeffrey; Hartenbach, Ellen; Adcock, Leon; Carson, Linda; Twiggs, Leo B.

In: Gynecologic Oncology, Vol. 51, No. 3, 12.1993, p. 307-310.

Research output: Contribution to journalArticle

Carter, J, Carlson, J, Fowler, J, Hartenbach, E, Adcock, L, Carson, L & Twiggs, LB 1993, 'Invasive Vulvar Tumors in Young Women-A Disease of the Immunosuppressed?', Gynecologic Oncology, vol. 51, no. 3, pp. 307-310. https://doi.org/10.1006/gyno.1993.1295
Carter J, Carlson J, Fowler J, Hartenbach E, Adcock L, Carson L et al. Invasive Vulvar Tumors in Young Women-A Disease of the Immunosuppressed? Gynecologic Oncology. 1993 Dec;51(3):307-310. https://doi.org/10.1006/gyno.1993.1295
Carter, Jonathan ; Carlson, Jay ; Fowler, Jeffrey ; Hartenbach, Ellen ; Adcock, Leon ; Carson, Linda ; Twiggs, Leo B. / Invasive Vulvar Tumors in Young Women-A Disease of the Immunosuppressed?. In: Gynecologic Oncology. 1993 ; Vol. 51, No. 3. pp. 307-310.
@article{5149c77f740b4c99af03ba0365130670,
title = "Invasive Vulvar Tumors in Young Women-A Disease of the Immunosuppressed?",
abstract = "Twenty-seven patients under the age of 40 years were treated for invasive vulvar cancer at the Women's Cancer Center, University of Minnesota. Seventeen patients had Stage I, five patients had Stage II, two patients had Stage III, and two patients had Stage IV disease. Twenty patients (80{\%}) gave a history of smoking. Associated medical and immunosuppressive conditions present in these patients included vulval HPV (N = 3), diabetes mellitus (N = 3), pregnancy (N = 2), autoimmune connective tissue disease (N = 2), renal transplant (N = 2), previous chemotherapy for invasive malignancies at other sites (N = 1), chronic hepatitis (N = 1), schizophrenia (N = 1), and one patient on Imuran for herpes zoster and multiple sclerosis. Two of the nonsmokers were in this group of immunosuppressed patients. Three patients have died of intercurrent disease while another is currently alive with invasive disease. All others are alive without evidence of disease. The mean duration of follow-up is 45.2 months (range, 1-158 months). Invasive vulvar tumors are uncommon in young women. Smoking and a history of an immunosuppressive medical illness is common in this patient population.",
author = "Jonathan Carter and Jay Carlson and Jeffrey Fowler and Ellen Hartenbach and Leon Adcock and Linda Carson and Twiggs, {Leo B.}",
year = "1993",
month = "12",
doi = "10.1006/gyno.1993.1295",
language = "English (US)",
volume = "51",
pages = "307--310",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Invasive Vulvar Tumors in Young Women-A Disease of the Immunosuppressed?

AU - Carter, Jonathan

AU - Carlson, Jay

AU - Fowler, Jeffrey

AU - Hartenbach, Ellen

AU - Adcock, Leon

AU - Carson, Linda

AU - Twiggs, Leo B.

PY - 1993/12

Y1 - 1993/12

N2 - Twenty-seven patients under the age of 40 years were treated for invasive vulvar cancer at the Women's Cancer Center, University of Minnesota. Seventeen patients had Stage I, five patients had Stage II, two patients had Stage III, and two patients had Stage IV disease. Twenty patients (80%) gave a history of smoking. Associated medical and immunosuppressive conditions present in these patients included vulval HPV (N = 3), diabetes mellitus (N = 3), pregnancy (N = 2), autoimmune connective tissue disease (N = 2), renal transplant (N = 2), previous chemotherapy for invasive malignancies at other sites (N = 1), chronic hepatitis (N = 1), schizophrenia (N = 1), and one patient on Imuran for herpes zoster and multiple sclerosis. Two of the nonsmokers were in this group of immunosuppressed patients. Three patients have died of intercurrent disease while another is currently alive with invasive disease. All others are alive without evidence of disease. The mean duration of follow-up is 45.2 months (range, 1-158 months). Invasive vulvar tumors are uncommon in young women. Smoking and a history of an immunosuppressive medical illness is common in this patient population.

AB - Twenty-seven patients under the age of 40 years were treated for invasive vulvar cancer at the Women's Cancer Center, University of Minnesota. Seventeen patients had Stage I, five patients had Stage II, two patients had Stage III, and two patients had Stage IV disease. Twenty patients (80%) gave a history of smoking. Associated medical and immunosuppressive conditions present in these patients included vulval HPV (N = 3), diabetes mellitus (N = 3), pregnancy (N = 2), autoimmune connective tissue disease (N = 2), renal transplant (N = 2), previous chemotherapy for invasive malignancies at other sites (N = 1), chronic hepatitis (N = 1), schizophrenia (N = 1), and one patient on Imuran for herpes zoster and multiple sclerosis. Two of the nonsmokers were in this group of immunosuppressed patients. Three patients have died of intercurrent disease while another is currently alive with invasive disease. All others are alive without evidence of disease. The mean duration of follow-up is 45.2 months (range, 1-158 months). Invasive vulvar tumors are uncommon in young women. Smoking and a history of an immunosuppressive medical illness is common in this patient population.

UR - http://www.scopus.com/inward/record.url?scp=0027768936&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027768936&partnerID=8YFLogxK

U2 - 10.1006/gyno.1993.1295

DO - 10.1006/gyno.1993.1295

M3 - Article

C2 - 8112637

AN - SCOPUS:0027768936

VL - 51

SP - 307

EP - 310

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 3

ER -